Very Low Blood Flow Carbon Dioxide Removal System is Not Effective in A Chronic Obstructive Pulmonary Disease Exacerbation Setting
The present retrospective study describes the first use of PrismaLung in severe COPD patients with acute exacerbation. When compared with a higher blood flow ECCO2R system, our results show that this novel, very low-flow device is not able to remove sufficient CO2, normalize pH or decrease respiratory rate.
